These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 36604405)
21. Hsa_circ_0069094 positively regulates the expression of oncogenic ZNF217 by competitively targeting miR-758-3p to promote the development of breast cancer. Ou H; Li J; Lv Q; Feng D Reprod Biol; 2022 Dec; 22(4):100708. PubMed ID: 36356557 [TBL] [Abstract][Full Text] [Related]
22. Circular_0086414 induces SPARC like 1 ( Jiang Q; Wang H; Yuan D; Qian X; Ma X; Yan M; Xing W Bioengineered; 2022 May; 13(5):12099-12114. PubMed ID: 35549806 [TBL] [Abstract][Full Text] [Related]
23. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway. Qi Q; Sun Y; Yang Y; Liu Y Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717 [TBL] [Abstract][Full Text] [Related]
24. Circ_0085616 contributes to the radio-resistance and progression of cervical cancer by targeting miR-541-3p/ARL2 signaling. Tang Y; Zhou L; Liu L Histol Histopathol; 2023 May; 38(5):571-584. PubMed ID: 36300495 [TBL] [Abstract][Full Text] [Related]
25. Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis. Zhang X; Zheng X Reprod Biol; 2022 Jun; 22(2):100648. PubMed ID: 35533615 [TBL] [Abstract][Full Text] [Related]
26. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling. Zheng H; Fu Q; Ma K; Shi S; Fu Y Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758 [TBL] [Abstract][Full Text] [Related]
27. Silencing circ_0000644 inhibits papillary thyroid cancer cell malignancy by combining with miR-671-5p to release the inhibition on ANXA2. Li HG; Zhao LH; Liu JZ; Liu KP; Liu JB; Su ZJ; Gao YJ J Endocrinol Invest; 2023 Apr; 46(4):749-761. PubMed ID: 36224454 [TBL] [Abstract][Full Text] [Related]
28. Circ_0057558 accelerates the development of prostate cancer through miR-1238-3p/SEPT2 axis. Yin Z; Zhang L; Liu R; Tong L; Jiang C; Kang L Pathol Res Pract; 2023 Mar; 243():154317. PubMed ID: 36738516 [TBL] [Abstract][Full Text] [Related]
29. Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis. Yu Q; Zhang Y; Tian Y; Peng A; Cui X; Ding B; Yang L; Liu Y; Ju Y; Gao C Appl Biochem Biotechnol; 2023 Dec; 195(12):7322-7337. PubMed ID: 36995659 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of circ_0058058 suppresses proliferation, angiogenesis and metastasis in multiple myeloma through miR-338-3p/ATG14 pathway. Xue L; Jia T; Zhu Y; Zhao L; Mao J J Orthop Surg Res; 2021 Dec; 16(1):723. PubMed ID: 34930344 [TBL] [Abstract][Full Text] [Related]
31. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis. Zhang Z; Mo Y; Wu L; Wang X; Liao G; Tan W; Li D Anticancer Drugs; 2022 Oct; 33(9):923-934. PubMed ID: 36136992 [TBL] [Abstract][Full Text] [Related]
32. Circ_0058124 Aggravates the Progression of Papillary Thyroid Carcinoma by Activating LMO4 Expression via Targeting miR-370-3p. Liu L; Yan C; Tao S; Wang H Cancer Manag Res; 2020; 12():9459-9470. PubMed ID: 33061633 [TBL] [Abstract][Full Text] [Related]
33. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis. Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115 [TBL] [Abstract][Full Text] [Related]
34. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis. Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291 [TBL] [Abstract][Full Text] [Related]
35. Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p. Chen X; Tang Y; Yan J; Li L; Jiang L; Chen Y J Dermatol Sci; 2021 Sep; 103(3):176-182. PubMed ID: 34454812 [TBL] [Abstract][Full Text] [Related]
36. Circ_0008673 regulates breast cancer malignancy by miR-153-3p/CFL2 axis. Zhang L; Zhang W; Zuo Z; Tang J; Song Y; Cao F; Yu X; Liu S; Cai X Arch Gynecol Obstet; 2022 Jan; 305(1):223-232. PubMed ID: 34324029 [TBL] [Abstract][Full Text] [Related]
37. CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis. Li X; Kong Y; Li H; Xu M; Jiang M; Sun W; Xu S Genes Genomics; 2021 May; 43(5):491-501. PubMed ID: 33709381 [TBL] [Abstract][Full Text] [Related]
38. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p. Zheng Y; Duan L; Yang Y; Luo D; Yan B Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879 [TBL] [Abstract][Full Text] [Related]
39. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p. Ma J; Kan Z Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055 [TBL] [Abstract][Full Text] [Related]
40. Circ_0003356 suppresses gastric cancer growth through targeting the miR-668-3p/SOCS3 axis. Li WD; Wang HT; Huang YM; Cheng BH; Xiang LJ; Zhou XH; Deng QY; Guo ZG; Yang ZF; Guan ZF; Wang Y World J Gastrointest Oncol; 2023 May; 15(5):787-809. PubMed ID: 37275445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]